 |
PDBsum entry 1qhs
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The crystal structures of chloramphenicol phosphotransferase reveal a novel inactivation mechanism.
|
 |
|
Authors
|
 |
T.Izard,
J.Ellis.
|
 |
|
Ref.
|
 |
Embo J, 2000,
19,
2690-2700.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Chloramphenicol (Cm), produced by the soil bacterium Streptomyces venezuelae, is
an inhibitor of bacterial ribosomal peptidyltransferase activity. The
Cm-producing streptomycete modifies the primary (C-3) hydroxyl of the antibiotic
by a novel Cm-inactivating enzyme, chloramphenicol 3-O-phosphotransferase (CPT).
Here we describe the crystal structures of CPT in the absence and presence of
bound substrates. The enzyme is dimeric in a sulfate-free solution and
tetramerization is induced by ammonium sulfate, the crystallization precipitant.
The tetrameric quaternary structure exhibits crystallographic 222 symmetry and
has ATP binding pockets located at a crystallographic 2-fold axis. Steric
hindrance allows only one ATP to bind per dimer within the tetramer. In addition
to active site binding by Cm, an electron-dense feature resembling the enzyme's
product is found at the other subunit interface. The structures of CPT suggest
that an aspartate acts as a general base to accept a proton from the 3-hydroxyl
of Cm, concurrent with nucleophilic attack of the resulting oxyanion on the
gamma-phosphate of ATP. Comparison between liganded and substrate-free CPT
structures highlights side chain movements of the active site's Arg136
guanidinium group of >9 A upon substrate binding.
|
 |
|
|
|
|
 |